Home LiteratureArticle Details
PMID: 680585 Published · ppublish English Journal Article

Long-term follow-up of chronic active hepatitis of moderate severity.

Gut ·Vol. 19 ·No. 6 ·1978-06-00 ·Pages 510-3

De Groote J, Fevery J, Lepoutre L

Abstract

A group of patients with only moderately active chronic hepatitis has been studied. The follow-up was long (mean 87 months). All patients except one were treated with prednisone and/or azathioprine. Of the hepatitis B virus positive patients two-thirds developed cirrhosis between the second and fifth year of evolution, while in the hepatitis B negative group this occurred in less than one-third. The transition to cirrhosis was clinically silent. The patients were all allowed to do their normal work except in the terminal stages of cirrhosis. Five patients died of causes related to the disease: three patients with cirrhosis and hepatocellular carcinoma, one with gallbladder carcinoma, and one from bleeding varices. The high incidence of tumour, especially liver-cell carcinoma, may be due to a cumulative effect of the presence of hepatitis B virus, cirrhotic transformation, and immuno-suppression. The other patients are currently in apparently good health.

MeSH Terms
Adult Alanine Transaminase/blood Azathioprine/therapeutic use Chronic Disease Female Follow-Up Studies Hepatitis/complications,drug therapy Hepatitis B virus Humans Liver Cirrhosis/etiology Male Middle Aged Prednisone/therapeutic use Time Factors
Chemicals
Alanine Transaminase Azathioprine Prednisone
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
De Groote J
Fevery J
Lepoutre L
References (13)
13 references, click to expand
  1. The immunology of acute and chronic hepatitis.
    Clin Gastroenterol. 1976 May;5(2):387-417 PMID: 1021327
  2. Protracted and recurrent forms of viral hepatitis.
    Am J Dis Child. 1972 Apr;123(4):283-6 PMID: 5027536
  3. Chronic active hepatitis in children.
    Am J Dig Dis. 1972 Jul;17(7):575-82 PMID: 4113452
  4. Detection of hepatitis-B antigen by radioimmunoassay in chronic liver disease and hepatocellular carcinoma in Great Britain.
    Lancet. 1973 Sep 29;2(7831):690-4 PMID: 4125788
  5. [Hepatitis-B-antigen in chronic liver diseases (author's transl)].
    Med Klin. 1973 Nov 16;68(46):1503-10 PMID: 4131487
  6. Hepatitis-associated antigen in chronic liver disease.
    Lancet. 1969 Sep 20;2(7621):609-12 PMID: 4185591
  7. A classification of chronic hepatitis.
    Lancet. 1968 Sep 14;2(7568):626-8 PMID: 4175170
  8. Australia antigen in acute and chronic liver disease.
    Lancet. 1969 Jul 19;2(7612):117-21 PMID: 4183241
  9. Hepatitis-associated antigen in chronic liver disease.
    Lancet. 1970 Jul 11;1(7663):100 PMID: 4193331
  10. Primary hepatoma in Uganda. A prospective clinical and epidemiologic study of forty-six patients.
    Am J Med. 1969 May;46(5):794-802 PMID: 4306948
  11. Active chronic hepatitis.
    Am J Med. 1970 Apr;48(4):484-95 PMID: 4912752
  12. Distribution patterns of hepatitis B surface antigen (HBsAg) in the liver of hepatitis patients.
    J Clin Pathol. 1976 Feb;29(2):94-100 PMID: 777039
  13. Hepatitis B surface antigen (HBsAg) in the liver of patients with hepatitis; a comparison with serological detection.
    J Clin Pathol. 1976 Feb;29(2):89-93 PMID: 777038
Article Info
Journal
Gut
Abbr.
Gut
ISSN
0017-5749
Published
1978-06-00
Pages
510-3
Language
English
Region
England
NLM ID
2985108R
PMCID
PMC1412017
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]